JP2018523978A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018523978A5 JP2018523978A5 JP2017564379A JP2017564379A JP2018523978A5 JP 2018523978 A5 JP2018523978 A5 JP 2018523978A5 JP 2017564379 A JP2017564379 A JP 2017564379A JP 2017564379 A JP2017564379 A JP 2017564379A JP 2018523978 A5 JP2018523978 A5 JP 2018523978A5
- Authority
- JP
- Japan
- Prior art keywords
- bacterium
- induced
- deficiency
- gene
- genetically engineered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (31)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562173710P | 2015-06-10 | 2015-06-10 | |
| US201562173706P | 2015-06-10 | 2015-06-10 | |
| US62/173,706 | 2015-06-10 | ||
| US62/173,710 | 2015-06-10 | ||
| US201562183935P | 2015-06-24 | 2015-06-24 | |
| US62/183,935 | 2015-06-24 | ||
| US201562184811P | 2015-06-25 | 2015-06-25 | |
| US201562184770P | 2015-06-25 | 2015-06-25 | |
| US62/184,811 | 2015-06-25 | ||
| US62/184,770 | 2015-06-25 | ||
| US201562248805P | 2015-10-30 | 2015-10-30 | |
| US62/248,805 | 2015-10-30 | ||
| US201562256048P | 2015-11-16 | 2015-11-16 | |
| US201562256041P | 2015-11-16 | 2015-11-16 | |
| US201562256039P | 2015-11-16 | 2015-11-16 | |
| US62/256,041 | 2015-11-16 | ||
| US62/256,039 | 2015-11-16 | ||
| US62/256,048 | 2015-11-16 | ||
| US201562263329P | 2015-12-04 | 2015-12-04 | |
| US14/960,333 | 2015-12-04 | ||
| US14/960,333 US9487764B2 (en) | 2014-12-05 | 2015-12-04 | Bacteria engineered to treat diseases associated with hyperammonemia |
| US62/263,329 | 2015-12-04 | ||
| US201662277654P | 2016-01-12 | 2016-01-12 | |
| US62/277,654 | 2016-01-12 | ||
| US201662291468P | 2016-02-04 | 2016-02-04 | |
| US62/291,468 | 2016-02-04 | ||
| US201662293749P | 2016-02-10 | 2016-02-10 | |
| US62/293,749 | 2016-02-10 | ||
| USPCT/US2016/020530 | 2016-03-02 | ||
| PCT/US2016/020530 WO2016141108A1 (en) | 2015-03-02 | 2016-03-02 | Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier |
| PCT/US2016/034200 WO2016200614A2 (en) | 2015-06-10 | 2016-05-25 | Bacteria engineered to treat diseases associated with hyperammonemia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020217391A Division JP2021061846A (ja) | 2015-06-10 | 2020-12-25 | 高アンモニア血症に関連する疾患を治療するために操作された細菌 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018523978A JP2018523978A (ja) | 2018-08-30 |
| JP2018523978A5 true JP2018523978A5 (https=) | 2019-06-20 |
| JP6817966B2 JP6817966B2 (ja) | 2021-01-20 |
Family
ID=57504262
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017564379A Expired - Fee Related JP6817966B2 (ja) | 2015-06-10 | 2016-05-25 | 高アンモニア血症に関連する疾患を治療するために操作された細菌 |
| JP2020217391A Pending JP2021061846A (ja) | 2015-06-10 | 2020-12-25 | 高アンモニア血症に関連する疾患を治療するために操作された細菌 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020217391A Pending JP2021061846A (ja) | 2015-06-10 | 2020-12-25 | 高アンモニア血症に関連する疾患を治療するために操作された細菌 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3307879A2 (https=) |
| JP (2) | JP6817966B2 (https=) |
| AU (1) | AU2016274311A1 (https=) |
| CA (1) | CA2988930A1 (https=) |
| WO (1) | WO2016200614A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017136795A1 (en) | 2016-02-04 | 2017-08-10 | Synlogic, Inc. | Bacteria engineered to treat diseases associated with tryptophan metabolism |
| IL270817B2 (en) * | 2017-05-24 | 2025-10-01 | Thoeris Gmbh | Use of glutamine synthetase to treat hyperammonemia |
| JP7460531B2 (ja) | 2017-12-05 | 2024-04-02 | バイオピーエルエックス，インコーポレイティド | 微生物感染を防ぐための方法および組成物 |
| CN110446259B (zh) * | 2018-05-04 | 2022-04-15 | 大唐移动通信设备有限公司 | 一种寻呼机会的位置确定方法及通信设备 |
| WO2020223345A1 (en) | 2019-04-29 | 2020-11-05 | Antipov Eugene | Enumeration of genetically engineered microorganisms by live cell counting techniques |
| WO2020239882A1 (en) | 2019-05-30 | 2020-12-03 | Recordati Industria Chimica E Farmaceutica S.P.A. | Pharmaceutical formulation for carglumic acid |
| AU2020288624B2 (en) | 2019-06-04 | 2025-09-25 | Cocoon Biotech Inc. | Silk-based products, formulations, and methods of use |
| WO2021107500A1 (ko) * | 2019-11-29 | 2021-06-03 | 주식회사 지니스 | 혈중 암모니아 수치 저하능을 갖는 균주 및 이를 포함하는 신경세포 보호용 조성물 |
| EP3839051A1 (en) * | 2019-12-19 | 2021-06-23 | Evonik Operations GmbH | Method for the fermentative production of guanidinoacetic acid |
| WO2022120028A2 (en) | 2020-12-02 | 2022-06-09 | Synlogic Operating Company, Inc. | Engineered microorganisms |
| WO2022210867A1 (ja) | 2021-03-31 | 2022-10-06 | 日本製鉄株式会社 | 無方向性電磁鋼板、無方向性電磁鋼板の打ち抜き方法および無方向性電磁鋼板の打ち抜き用金型 |
| CN119592452B (zh) * | 2024-11-23 | 2025-12-02 | 清华大学 | 洋葱伯克霍尔德菌及其浸出废料中稀土元素的方法 |
| CN120000813A (zh) * | 2025-02-17 | 2025-05-16 | 温州医科大学 | 工程益生菌在防治阿尔茨海默病中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3083315B2 (ja) * | 1990-10-29 | 2000-09-04 | 株式会社ヤクルト本社 | 血中アンモニア低下剤 |
| GB9107305D0 (en) | 1991-04-08 | 1991-05-22 | Unilever Plc | Probiotic |
| IT1290679B1 (it) * | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| US6203797B1 (en) | 1998-01-06 | 2001-03-20 | Stephen C. Perry | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome |
| EP1135461A4 (en) | 1998-12-02 | 2003-03-26 | Univ Boston | GEN NETWORKS FOR CONTROLLING GENE EXPRESSION |
| EP1034787A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| US7731976B2 (en) | 2003-08-29 | 2010-06-08 | Cobb And Company, Llp | Treatment of irritable bowel syndrome using probiotic composition |
| WO2009123029A1 (ja) * | 2008-03-31 | 2009-10-08 | 株式会社 大塚製薬工場 | 血中アンモニア調整剤 |
| AU2014331610B2 (en) * | 2013-10-03 | 2019-11-07 | Trustees Of The University Of Pennsylvania | Compositions comprising a defined microbiome and methods of use thereof |
-
2016
- 2016-05-25 AU AU2016274311A patent/AU2016274311A1/en not_active Abandoned
- 2016-05-25 CA CA2988930A patent/CA2988930A1/en not_active Abandoned
- 2016-05-25 JP JP2017564379A patent/JP6817966B2/ja not_active Expired - Fee Related
- 2016-05-25 EP EP16731402.0A patent/EP3307879A2/en not_active Withdrawn
- 2016-05-25 WO PCT/US2016/034200 patent/WO2016200614A2/en not_active Ceased
-
2020
- 2020-12-25 JP JP2020217391A patent/JP2021061846A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018523978A5 (https=) | ||
| JP6768689B2 (ja) | 高アンモニア血症に関連する病気を処置するために操作された細菌 | |
| JP7407120B2 (ja) | シンバイオティクス組成物 | |
| Schöpping et al. | Stress response in bifidobacteria | |
| US20210095297A1 (en) | Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal Barrier | |
| Nanda et al. | Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions | |
| JP6817966B2 (ja) | 高アンモニア血症に関連する疾患を治療するために操作された細菌 | |
| EP3307870B1 (en) | Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acid | |
| JP2018515106A5 (https=) | ||
| BR112017018656B1 (pt) | Bactéria geneticamente modificada, composição farmaceuticamente aceitável compreendendo a dita bactéria e uso da dita composição para tratar ou prevenir uma doença ou condição associada à inflamação intestinal e/ou função da barreira intestinal comprometida | |
| JP2020525012A5 (https=) | ||
| Wei et al. | Adaptational changes in physiological and transcriptional responses of Bifidobacterium longum involved in acid stress resistance after successive batch cultures | |
| EP3227440B1 (en) | Bacteria engineered to treat diseases associated with hyperammonemia | |
| Xu et al. | Metabolic engineering of Lactococcus lactis for high level accumulation of glutathione and S-adenosyl-L-methionine | |
| WO2016210378A2 (en) | Multi-layered control of gene expression in genetically engineered bacteria | |
| EP3541942B1 (en) | Conjugative vectors selectable by fructooligosaccharides | |
| Sulek et al. | Metabolic footprint of Lactobacillus acidophilus NCFM at different pH | |
| Jeong et al. | Lactobacillus plantarum LRCC5314 Includes a Gene for a Substance that Stimulates the Secretion of Serotonin | |
| RU2799354C2 (ru) | Синбиотические композиции | |
| KAUR et al. | Mechanism of Endogenous Oxalate Synthesis and Its Degradation by Probiotic Bacteria in Humans. | |
| CA3097270C (en) | Synbiotic compositions | |
| Shen | The Role of Gut Microbiota Urease in the Host With Liver Disease | |
| AU2024287571A1 (en) | Modified bacterium having anti-tumor activity and better safety | |
| HK40038440A (en) | Synbiotic compositions | |
| HK40038440B (en) | Synbiotic compositions |